405 related articles for article (PubMed ID: 26506116)
1. Skin collagen pentosidine and fluorescence in diabetes were predictors of retinopathy progression and creatininemia increase already 6years after punch-biopsy.
Sternberg M; M'bemba J; Urios P; Borsos AM; Selam JL; Peyroux J; Slama G
Clin Biochem; 2016 Feb; 49(3):225-31. PubMed ID: 26506116
[TBL] [Abstract][Full Text] [Related]
2. Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM.
Sell DR; Lapolla A; Odetti P; Fogarty J; Monnier VM
Diabetes; 1992 Oct; 41(10):1286-92. PubMed ID: 1397702
[TBL] [Abstract][Full Text] [Related]
3. Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients.
Kerkeni M; Saïdi A; Bouzidi H; Letaief A; Ben Yahia S; Hammami M
Diab Vasc Dis Res; 2013 May; 10(3):239-45. PubMed ID: 23091285
[TBL] [Abstract][Full Text] [Related]
4. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes.
Genuth S; Sun W; Cleary P; Sell DR; Dahms W; Malone J; Sivitz W; Monnier VM;
Diabetes; 2005 Nov; 54(11):3103-11. PubMed ID: 16249432
[TBL] [Abstract][Full Text] [Related]
5. Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy.
Beisswenger PJ; Moore LL; Brinck-Johnsen T; Curphey TJ
J Clin Invest; 1993 Jul; 92(1):212-7. PubMed ID: 8325987
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of pentosidine in diabetic patients: an advanced glycation end product.
Sugiyama S; Miyata T; Ueda Y; Tanaka H; Maeda K; Kawashima S; Van Ypersele de Strihou C; Kurokawa K
J Am Soc Nephrol; 1998 Sep; 9(9):1681-8. PubMed ID: 9727377
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes.
Miura J; Yamagishi Si; Uchigata Y; Takeuchi M; Yamamoto H; Makita Z; Iwamoto Y
J Diabetes Complications; 2003; 17(1):16-21. PubMed ID: 12505751
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum levels of AGEs, sRAGE, and pentosidine in Tunisian patients with severity of diabetic retinopathy.
Kerkeni M; Saïdi A; Bouzidi H; Ben Yahya S; Hammami M
Microvasc Res; 2012 Nov; 84(3):378-83. PubMed ID: 22835520
[TBL] [Abstract][Full Text] [Related]
9. Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes.
Beisswenger PJ; Makita Z; Curphey TJ; Moore LL; Jean S; Brinck-Johnsen T; Bucala R; Vlassara H
Diabetes; 1995 Jul; 44(7):824-9. PubMed ID: 7789650
[TBL] [Abstract][Full Text] [Related]
10. Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes.
Monnier VM; Sun W; Gao X; Sell DR; Cleary PA; Lachin JM; Genuth S;
Cardiovasc Diabetol; 2015 Sep; 14():118. PubMed ID: 26341632
[TBL] [Abstract][Full Text] [Related]
11. Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes.
Genuth S; Sun W; Cleary P; Gao X; Sell DR; Lachin J; ; Monnier VM
Diabetes; 2015 Jan; 64(1):266-78. PubMed ID: 25187362
[TBL] [Abstract][Full Text] [Related]
12. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus.
McCance DR; Dyer DG; Dunn JA; Bailie KE; Thorpe SR; Baynes JW; Lyons TJ
J Clin Invest; 1993 Jun; 91(6):2470-8. PubMed ID: 8514859
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.
Horie K; Miyata T; Maeda K; Miyata S; Sugiyama S; Sakai H; van Ypersole de Strihou C; Monnier VM; Witztum JL; Kurokawa K
J Clin Invest; 1997 Dec; 100(12):2995-3004. PubMed ID: 9399945
[TBL] [Abstract][Full Text] [Related]
14. Simple non-invasive assessment of advanced glycation endproduct accumulation.
Meerwaldt R; Graaff R; Oomen PHN; Links TP; Jager JJ; Alderson NL; Thorpe SR; Baynes JW; Gans ROB; Smit AJ
Diabetologia; 2004 Jul; 47(7):1324-1330. PubMed ID: 15243705
[TBL] [Abstract][Full Text] [Related]
15. Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes.
Hirata K; Kubo K
Endocr J; 2004 Dec; 51(6):537-44. PubMed ID: 15644571
[TBL] [Abstract][Full Text] [Related]
16. Vitreous advanced glycation endproducts and α-dicarbonyls in retinal detachment patients with type 2 diabetes mellitus and non-diabetic controls.
Fokkens BT; Mulder DJ; Schalkwijk CG; Scheijen JL; Smit AJ; Los LI
PLoS One; 2017; 12(3):e0173379. PubMed ID: 28264049
[TBL] [Abstract][Full Text] [Related]
17. Two fluorescent wavelengths, 440(ex)/520(em) nm and 370(ex)/440(em) nm, reflect advanced glycation and oxidation end products in human skin without diabetes.
Beisswenger PJ; Howell S; Mackenzie T; Corstjens H; Muizzuddin N; Matsui MS
Diabetes Technol Ther; 2012 Mar; 14(3):285-92. PubMed ID: 22023375
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS.
Seftel AD; Vaziri ND; Ni Z; Razmjouei K; Fogarty J; Hampel N; Polak J; Wang RZ; Ferguson K; Block C; Haas C
Urology; 1997 Dec; 50(6):1016-26. PubMed ID: 9426743
[TBL] [Abstract][Full Text] [Related]
19. Plasma homocysteine and microvascular complications in type 1 diabetes.
Vaccaro O; Perna AF; Mancini FP; Iovine C; Cuomo V; Sacco M; Tufano A; Rivellese AA; Ingrosso D; Riccardi G
Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):297-304. PubMed ID: 11302003
[TBL] [Abstract][Full Text] [Related]
20. The association between skin collagen glucosepane and past progression of microvascular and neuropathic complications in type 1 diabetes.
Monnier VM; Sell DR; Strauch C; Sun W; Lachin JM; Cleary PA; Genuth S;
J Diabetes Complications; 2013; 27(2):141-9. PubMed ID: 23153673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
